How to Develop Drug Delivery System Based on Carbohydrate Nanoparticles Targeted to Brain Tumors

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Brain tumors present significant therapeutic challenges due to diverse forms, limited effective chemotherapies, and the blood-brain barrier (BBB).
• Nanoparticles (1-500 nm) are emerging as advanced drug delivery systems, driven by nanotechnology advancements.
• Carbohydrate-based nanoparticles offer biocompatibility, biodegradability, and reduced toxicity for molecular transport.

Purpose of the Study:

• To review the synthesis and modification strategies for carbohydrate nanoparticles.
• To provide an overview of the biological and clinical outcomes associated with carbohydrate nanocarriers.
• To highlight the potential of carbohydrate nanocarriers for targeted drug delivery in gliomas and glioblastomas.

Main Methods:

• Literature review focusing on carbohydrate nanoparticle synthesis and modification.
• Analysis of existing studies on the biological activity and clinical applications of these nanocarriers.
• Exploration of challenges in the design and fabrication of biopolymer colloidal nanomaterials.

Main Results:

• Carbohydrate nanoparticles demonstrate potential for overcoming the BBB, enhancing drug delivery to brain tumors.
• These nanocarriers exhibit favorable biocompatibility and biodegradability, minimizing systemic toxicity.
• The review synthesizes current knowledge on fabrication techniques and therapeutic efficacy.

Conclusions:

• Carbohydrate-based nanoparticles represent a promising platform for targeted drug delivery in neuro-oncology.
• Further research into their design and fabrication is crucial for clinical translation.
• These nanocarriers hold significant potential for improving treatment outcomes for high-grade gliomas and glioblastomas.